Measuring higher-order drug interactions: A review of recent approaches-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Measuring higher-order drug interactions: A review of recent approaches

Published:2017-08 Issue: Volume:4 Page:16-23
ISSN:2452-3100
Container-title:Current Opinion in Systems Biology
language:en
Short-container-title:Current Opinion in Systems Biology

Author:

Tekin Elif,Savage Van M.,Yeh Pamela J.

Funder

James F. McDonnell Complex Systems

NSF DBI

UCLA

Hellman Foundation

Publisher

Elsevier BV

Subject

Applied Mathematics,Computer Science Applications,Drug Discovery,General Biochemistry, Genetics and Molecular Biology,Modelling and Simulation

Reference37 articles.

1. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team;Hammer;N Engl J Med,1996

2. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less;Hammer;N Engl J Med,1997

3. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial;Diacon;Lancet,2012

4. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial;Durie;Lancet,2017

5. Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study;Kohli;Lancet,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying higher-order epistasis: beware the chimera;2024-07-19

2. Evolutionary druggability for low-dimensional fitness landscapes toward new metrics for antimicrobial applications;eLife;2024-06-04

3. Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis;Antimicrobial Agents and Chemotherapy;2024-05-02

4. CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders;International Journal of Molecular Sciences;2024-01-07

5. Evolutionary druggability: leveraging low-dimensional fitness landscapes towards new metrics for antimicrobial applications;ELIFE;2023-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3